We are analyzing https://link.springer.com/article/10.1007/s12072-015-9656-7.

Title:
Bile acids: emerging role in management of liver diseases | Hepatology International
Description:
Bile acids are well known for their effects on cholesterol homeostasis and lipid digestion. Since the discovery of bile acid receptors, of which there are farnesoid X receptor (FXR), a nuclear receptor, and the plasma membrane G-protein receptor, as well as Takeda G-protein coupled receptor clone 5, further roles have been elucidated for bile acids including glucose and lipid metabolism as well as inflammation. Additionally, treatment with bile acid receptor agonists has shown a decrease in the amount of atherosclerosis plaque formation and decreased portal vascular resistance and portal hypotension in animal models. Furthermore, rodent models have demonstrated antifibrotic activity using bile acid receptor agonists. Early human data using a FXR agonist, obeticholic acid, have shown promising results with improvement of histological activity and even a reduction of fibrosis. Human studies are ongoing and will provide further information on bile acid receptor agonist therapies. Thus, bile acids and their derivatives have the potential for management of liver diseases and potentially other disease states including diabetes and the metabolic syndrome.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Environment

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,603,724 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

bile, pubmed, article, google, scholar, cas, acids, receptor, acid, central, nuclear, res, lipid, liver, fxr, metabolism, receptors, tgr, role, sanyal, disease, hofmann, privacy, cookies, content, research, kumar, farnesoid, glucose, regulation, signaling, function, data, information, publish, search, emerging, diseases, asgharpour, divya, metabolic, access, chapter, rev, biochem, chiang, pharmacol, intestinal, cell, usa,

Topics {✒️}

reporters/pages/interim-results-flint-clinical-trial divya kumar & arun sanyal protein-coupled receptor responsive month download article/chapter neuschwander-tetri ba nuclear hormone receptors bile acid-activated receptors nuclear receptors sxr/pxr divya kumar declares nuclear receptor fxr/bar bile acid receptors full article pdf hofmann af membrane-type receptor privacy choices/manage cookies emerging therapeutic target nuclear receptor pxr normal glucose homeostasis bunnett nw placebo-controlled trial orphan nuclear receptor multipurpose nuclear receptor bile acid solubility bile acid transporters author information authors bile acid signaling lithocholic acid sensor endogenous bile acids cholestatic bile acids bile acids recognition bile acid absorption shown promising results amon asgharpour declares bile salt biotransformations bile acid synthesis article asgharpour tgr5 receptor intestinal disease bile acid regulation european economic area dietschy jm kullak-ublick ga improves portal hypertension bristol myers-squibb neuro-humoral signaling nutrient signaling hormones conditions privacy policy hylemon pb article log demonstrated antifibrotic activity

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Bile acids: emerging role in management of liver diseases
         description:Bile acids are well known for their effects on cholesterol homeostasis and lipid digestion. Since the discovery of bile acid receptors, of which there are farnesoid X receptor (FXR), a nuclear receptor, and the plasma membrane G-protein receptor, as well as Takeda G-protein coupled receptor clone 5, further roles have been elucidated for bile acids including glucose and lipid metabolism as well as inflammation. Additionally, treatment with bile acid receptor agonists has shown a decrease in the amount of atherosclerosis plaque formation and decreased portal vascular resistance and portal hypotension in animal models. Furthermore, rodent models have demonstrated antifibrotic activity using bile acid receptor agonists. Early human data using a FXR agonist, obeticholic acid, have shown promising results with improvement of histological activity and even a reduction of fibrosis. Human studies are ongoing and will provide further information on bile acid receptor agonist therapies. Thus, bile acids and their derivatives have the potential for management of liver diseases and potentially other disease states including diabetes and the metabolic syndrome.
         datePublished:2015-08-29T00:00:00Z
         dateModified:2015-08-29T00:00:00Z
         pageStart:527
         pageEnd:533
         sameAs:https://doi.org/10.1007/s12072-015-9656-7
         keywords:
            Bile acids
            FXR
            TGR5
            Liver disease
            Hepatology
            Colorectal Surgery
            Surgery
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12072-015-9656-7/MediaObjects/12072_2015_9656_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12072-015-9656-7/MediaObjects/12072_2015_9656_Fig2_HTML.gif
         isPartOf:
            name:Hepatology International
            issn:
               1936-0541
               1936-0533
            volumeNumber:9
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer India
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Amon Asgharpour
               url:http://orcid.org/0000-0002-3545-8703
               affiliation:
                     name:Virginia Commonwealth University
                     address:
                        name:Virginia Commonwealth University, Richmond, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Divya Kumar
               affiliation:
                     name:Virginia Commonwealth University
                     address:
                        name:Virginia Commonwealth University, Richmond, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Arun Sanyal
               affiliation:
                     name:Virginia Commonwealth University
                     address:
                        name:Virginia Commonwealth University, Richmond, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Bile acids: emerging role in management of liver diseases
      description:Bile acids are well known for their effects on cholesterol homeostasis and lipid digestion. Since the discovery of bile acid receptors, of which there are farnesoid X receptor (FXR), a nuclear receptor, and the plasma membrane G-protein receptor, as well as Takeda G-protein coupled receptor clone 5, further roles have been elucidated for bile acids including glucose and lipid metabolism as well as inflammation. Additionally, treatment with bile acid receptor agonists has shown a decrease in the amount of atherosclerosis plaque formation and decreased portal vascular resistance and portal hypotension in animal models. Furthermore, rodent models have demonstrated antifibrotic activity using bile acid receptor agonists. Early human data using a FXR agonist, obeticholic acid, have shown promising results with improvement of histological activity and even a reduction of fibrosis. Human studies are ongoing and will provide further information on bile acid receptor agonist therapies. Thus, bile acids and their derivatives have the potential for management of liver diseases and potentially other disease states including diabetes and the metabolic syndrome.
      datePublished:2015-08-29T00:00:00Z
      dateModified:2015-08-29T00:00:00Z
      pageStart:527
      pageEnd:533
      sameAs:https://doi.org/10.1007/s12072-015-9656-7
      keywords:
         Bile acids
         FXR
         TGR5
         Liver disease
         Hepatology
         Colorectal Surgery
         Surgery
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12072-015-9656-7/MediaObjects/12072_2015_9656_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12072-015-9656-7/MediaObjects/12072_2015_9656_Fig2_HTML.gif
      isPartOf:
         name:Hepatology International
         issn:
            1936-0541
            1936-0533
         volumeNumber:9
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer India
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Amon Asgharpour
            url:http://orcid.org/0000-0002-3545-8703
            affiliation:
                  name:Virginia Commonwealth University
                  address:
                     name:Virginia Commonwealth University, Richmond, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Divya Kumar
            affiliation:
                  name:Virginia Commonwealth University
                  address:
                     name:Virginia Commonwealth University, Richmond, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Arun Sanyal
            affiliation:
                  name:Virginia Commonwealth University
                  address:
                     name:Virginia Commonwealth University, Richmond, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Hepatology International
      issn:
         1936-0541
         1936-0533
      volumeNumber:9
Organization:
      name:Springer India
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Virginia Commonwealth University
      address:
         name:Virginia Commonwealth University, Richmond, USA
         type:PostalAddress
      name:Virginia Commonwealth University
      address:
         name:Virginia Commonwealth University, Richmond, USA
         type:PostalAddress
      name:Virginia Commonwealth University
      address:
         name:Virginia Commonwealth University, Richmond, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Amon Asgharpour
      url:http://orcid.org/0000-0002-3545-8703
      affiliation:
            name:Virginia Commonwealth University
            address:
               name:Virginia Commonwealth University, Richmond, USA
               type:PostalAddress
            type:Organization
      name:Divya Kumar
      affiliation:
            name:Virginia Commonwealth University
            address:
               name:Virginia Commonwealth University, Richmond, USA
               type:PostalAddress
            type:Organization
      name:Arun Sanyal
      affiliation:
            name:Virginia Commonwealth University
            address:
               name:Virginia Commonwealth University, Richmond, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Virginia Commonwealth University, Richmond, USA
      name:Virginia Commonwealth University, Richmond, USA
      name:Virginia Commonwealth University, Richmond, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(174)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.91s.

LINK . SPRINGER . COM {}